![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:0171C GW Pharmaceuticals PLC 14 August 2007 GW Pharmaceuticals PLC ("GW") In conformity with the Transparency Directive's transitional provision 6, GW hereby provides notification of the following information: GW's issued capital consists of 120,297,135 ordinary shares of 0.1p each with voting rights. Therefore, the total number of voting rights in GW is 120,297,135. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, GW under the FSA's Disclosure and Transparency Rules. For further information, please contact: GW Pharmaceuticals PLC +44 (0)1980 557 000 Jonathan Laughton, Company Secretary This information is provided by RNS The company news service from the London Stock Exchange END TVRKGGMRVFLGNZM
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions